Fibroblast Growth Factor-23 As a Biomarker of Adverse Outcomes in Patients with Coronary Artery Disease: a Meta-Analysis
Biomarkers（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined